《半日速報》恆指半日收報17,577點 升111點; 恆生科技指數半日收報3,838點 升21點 藥明生物升逾5%
恆指半日收17,577點,升111點或0.6%。恆生科技指數報3,838點,升21點或0.6%。國指升42點或0.7%,報6,072點。
活躍重磅股表現:
美團(03690.HK) 收114.9元,下跌1.2%;
港交所(00388.HK) 收291.4元,上升1.1%;
阿里巴巴(09988.HK) 收84.6元,上升0.8%;
平安(02318.HK) 收45.1元,上升0.7%;
騰訊(00700.HK) 收302元,上升0.7%;
友邦(01299.HK) 收61.9元,上升0.4%;
異動恆指及國指成份股:
藥明生物(02269.HK) 收45.2元,上升5.2%;
異動綜合中小型股:
嘉里物流(00636.HK) 收7.22元,上升14.6%;
馬可數字科技(01942.HK) 收7.96元,下跌14.3%;
普達特科技(00650.HK) 收0.475元,上升10.5%;
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.